Retatrutide is an investigational peptide drug developed by Eli Lilly that acts as a triple agonist, simultaneously targeting three hormone receptors: glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors
Dementia is a complex condition with multiple contributing factors, including genetics, lifestyle, and other medical conditions. If I want a B12 supplement, what kind should I get
Rotating injection sites prevents this from becoming problematic
Am J Gastroenterol
In addition to hematologists, our case also highlights the importance of other subspecialties, including gastroenterology and intensivists' role in recognizing the complications of severe vitamin B12 deficiency
Scott has been quoted in the Wall Street Journal, WSJ.com and various other investment related publications